Igor Gitelman Email

Interim Chief Financial Officer . Advaxis

Current Roles

Employees:
56
Revenue:
$15M
About
Advaxis, Inc. is a biotechnology company based upon the concept that in order to treat cancer and other diseases immunologically it is best to use a modified infectious micro-organism to elicit the most profound immune response possible, as this is what the immune system evolved to address. Based upon over a 10 years of innovative work done by Yvonne Paterson, Ph.D., Professor of Microbiology at the University of Pennsylvania, it has been found that the unique microbe Listeria monocytogenes is capable of simultaneously stimulating every numerous aspects of the immune sys. tem simultaneously; thus coordinating innate, humoral (antibody), and cellular adaptive immune responses in an extremely effective response to existing cancers and other diseases. Unlike other therapeutic approaches, Advaxis’ Listeria technology has been able to constantly demonstrate complete therapeutic responses resulting in complete tumor regression, even in the presence of immune tolerance. The Company is the exclusive licensee of a broadly enabling platform technology for creating cancer vaccines and therapies for infectious diseases and other immune problems based upon genetically modified Listeria.
Advaxis Address
305 College Rd East
Princeton, NJ
United States
Advaxis Email

Past Companies

Ayala Parmacuticals Inc (f/k/a Advaxis, Inc.)Interim Chief Financial Officer
Accu Reference Medical LabChief Financial Officer
Cancer Genetics, Inc.Chief Accounting Officer

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.